|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.AU |
First Approval Date20 Aug 2018 |
100 Clinical Results associated with Boucher & Muir Pty Ltd.
0 Patents (Medical) associated with Boucher & Muir Pty Ltd.
100 Deals associated with Boucher & Muir Pty Ltd.
100 Translational Medicine associated with Boucher & Muir Pty Ltd.